JPH046699B2 - - Google Patents
Info
- Publication number
- JPH046699B2 JPH046699B2 JP2147167A JP14716790A JPH046699B2 JP H046699 B2 JPH046699 B2 JP H046699B2 JP 2147167 A JP2147167 A JP 2147167A JP 14716790 A JP14716790 A JP 14716790A JP H046699 B2 JPH046699 B2 JP H046699B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt
- enantiomer
- uptake
- racemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Luminescent Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20649880A | 1980-11-14 | 1980-11-14 | |
| US206498 | 1980-11-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56182953A Division JPS57114555A (en) | 1980-11-14 | 1981-11-13 | 3-aryloxy-3-phenylpropylamine and manufacture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH037251A JPH037251A (ja) | 1991-01-14 |
| JPH046699B2 true JPH046699B2 (OSRAM) | 1992-02-06 |
Family
ID=22766667
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56182953A Granted JPS57114555A (en) | 1980-11-14 | 1981-11-13 | 3-aryloxy-3-phenylpropylamine and manufacture |
| JP2147166A Granted JPH037250A (ja) | 1980-11-14 | 1990-06-05 | （―）―ｎ―メチル―３―（２―メチルフェノキシ）―３―フェニルプロピルアミン |
| JP2147167A Granted JPH037251A (ja) | 1980-11-14 | 1990-06-05 | （―）―ｎ―メチル―３―（２―メチルフェノキシ）―３―フェニルプロピルアミンの製造法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56182953A Granted JPS57114555A (en) | 1980-11-14 | 1981-11-13 | 3-aryloxy-3-phenylpropylamine and manufacture |
| JP2147166A Granted JPH037250A (ja) | 1980-11-14 | 1990-06-05 | （―）―ｎ―メチル―３―（２―メチルフェノキシ）―３―フェニルプロピルアミン |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP0052492B1 (OSRAM) |
| JP (3) | JPS57114555A (OSRAM) |
| KR (1) | KR830007508A (OSRAM) |
| AT (1) | ATE6422T1 (OSRAM) |
| AU (1) | AU540707B2 (OSRAM) |
| CA (1) | CA1181430A (OSRAM) |
| CS (1) | CS227019B2 (OSRAM) |
| CY (1) | CY1350A (OSRAM) |
| DD (1) | DD201139A5 (OSRAM) |
| DE (1) | DE3162445D1 (OSRAM) |
| DK (1) | DK161887C (OSRAM) |
| EG (1) | EG15458A (OSRAM) |
| ES (1) | ES8206440A1 (OSRAM) |
| FI (1) | FI77018C (OSRAM) |
| GB (1) | GB2087883A (OSRAM) |
| GR (1) | GR75395B (OSRAM) |
| HK (1) | HK16087A (OSRAM) |
| HU (1) | HU185475B (OSRAM) |
| IE (1) | IE52170B1 (OSRAM) |
| IL (1) | IL64288A (OSRAM) |
| MY (1) | MY8700709A (OSRAM) |
| NZ (1) | NZ198953A (OSRAM) |
| PH (1) | PH17424A (OSRAM) |
| PL (1) | PL233786A1 (OSRAM) |
| PT (1) | PT73982B (OSRAM) |
| RO (1) | RO83309B (OSRAM) |
| SU (1) | SU1068034A3 (OSRAM) |
| ZA (1) | ZA817863B (OSRAM) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777291A (en) * | 1985-02-27 | 1988-10-11 | Eli Lilly And Company | Racemization process |
| US4797286A (en) * | 1985-11-12 | 1989-01-10 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulations |
| US5112619A (en) * | 1985-11-12 | 1992-05-12 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulation |
| GB8823405D0 (en) * | 1988-10-05 | 1988-11-09 | Erba Carlo Spa | Aryloxy-arythio-heteraryloxy-heteroarylthio-alkenylene derivatives of amines |
| DK258389D0 (da) * | 1989-05-26 | 1989-05-26 | Ferrosan As | Aryloxyphenylpropylaminer, deres fremstilling og anvendelse |
| CA2061665C (en) * | 1991-02-25 | 2002-04-16 | Mark Mortensen Foreman | Treatment of lower urinary tract disorders |
| EP1022025A3 (en) * | 1991-06-26 | 2002-06-05 | Sepracor, Inc. | Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron |
| JPH07500812A (ja) * | 1991-11-15 | 1995-01-26 | セプラコア，インコーポレーテッド | 純粋なフルオキセチンのｓ（＋）異性体を用いる方法および組成物 |
| JPH07501547A (ja) * | 1991-11-26 | 1995-02-16 | セプラコア，インコーポレーテッド | 光学的に純粋な（−）アムロジピンを用いる，高血圧，狭心症および他の疾患を治療するための方法および組成物 |
| EP0576766A1 (en) * | 1992-06-29 | 1994-01-05 | Novo Nordisk A/S | Propanolamine derivatives, their preparation and use |
| TW344661B (en) * | 1993-11-24 | 1998-11-11 | Lilly Co Eli | Pharmaceutical composition for treatment of incontinence |
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| EP1181015A2 (en) | 1999-03-01 | 2002-02-27 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| WO2000058262A1 (en) * | 1999-03-29 | 2000-10-05 | Eli Lilly And Company | Stereospecific method for preparing tomoxetine and intermediates thereof |
| DK1171417T3 (da) | 1999-04-09 | 2006-02-20 | Lilly Co Eli | Fremgangsmåde til fremstilling af 3-aryloxy-3-arylpropylaminer og mellemprodukter deraf |
| DE19955190A1 (de) * | 1999-11-16 | 2001-06-21 | Sanol Arznei Schwarz Gmbh | Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| CN1649614A (zh) | 2002-02-22 | 2005-08-03 | 新河药品股份有限公司 | 活性剂传递系统和保护及施用活性剂的方法 |
| GB0229583D0 (en) | 2002-12-19 | 2003-01-22 | Cipla Ltd | A process for preparing duloxetine and intermediates for use therein |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US8545881B2 (en) | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
| WO2006068662A1 (en) | 2004-06-28 | 2006-06-29 | Teva Pharmaceutical Fine Chemicals S.R.L. | Processes for the preparation of tomoxetine |
| US7439399B2 (en) | 2004-06-28 | 2008-10-21 | Teva Pharmaceutical Fine Chemicals | Processes for the preparation of atomoxetine hydrochloride |
| US7473804B2 (en) | 2004-07-22 | 2009-01-06 | Teva Pharmaceutical Fine Chemicals S.R.L. | Polymorphs of atomoxetine hydrochloride |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| WO2006047493A2 (en) | 2004-10-21 | 2006-05-04 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| JP2008501721A (ja) * | 2005-04-05 | 2008-01-24 | テバ ファーマシューティカル ファイン ケミカルズ ソチエタ レスポンサビリタ リミテ | 安定性アトモキセチン塩酸塩、その調製方法及びその安定性の分析的調節 |
| EP1889828A1 (en) * | 2005-04-05 | 2008-02-20 | Teva Pharmaceutical Fine Chemicals S.R.L. | Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| US7485754B2 (en) | 2005-07-08 | 2009-02-03 | Apotex Pharmachem Inc. | Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers |
| CZ296345B6 (cs) * | 2005-07-21 | 2006-02-15 | Zentiva, A. S | Zpusob výroby hydrochloridu (R)-N-methyl-3-(2-methylfenoxy)-3-fenylpropylaminu (atomoxetinu) |
| EP1798215A1 (en) | 2005-12-14 | 2007-06-20 | SOLMAG S.p.A. | Polymorph of atomoxetine hydrochloride in crystalline form |
| ITMI20061987A1 (it) * | 2006-10-16 | 2008-04-17 | Archimica Srl | Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine. |
| WO2008062473A1 (en) * | 2006-10-31 | 2008-05-29 | Cadila Healthcare Limited | Process for preparing atomoxetine hydrochloride |
| CN100430370C (zh) * | 2006-11-03 | 2008-11-05 | 华东理工大学 | 一种丙胺衍生物及其在制备托莫西汀中的应用 |
| WO2009141833A2 (en) * | 2008-04-17 | 2009-11-26 | Ind-Swift Laboratories Limited | An improved process for synthesizing highly pure atomoxetine |
| EP2506836B1 (en) | 2009-12-02 | 2018-02-14 | Adare Pharmaceuticals S.R.L. | Fexofenadine microcapsules and compositions containing them |
| CN105705135A (zh) | 2013-11-08 | 2016-06-22 | 伊莱利利公司 | 阿托莫西汀溶液 |
| GR1008531B (el) | 2014-03-21 | 2015-07-13 | Λαμδα Φαρμακευτικα Εργαστηρια Εφαμροσμενης Ερευνας Και Αναπτυξης Α.Ε., | Ποσιμα διαλυματα που περιεχουν υδροχλωρικη ατομοξετινη |
| EP3069715A1 (en) | 2015-03-20 | 2016-09-21 | Salmon Pharma GmbH | Immediate release dosage forms of Atomoxetine |
| CN106916074A (zh) * | 2017-02-14 | 2017-07-04 | 万特制药(海南)有限公司 | 盐酸托莫西汀的制备 |
| CN110294680A (zh) * | 2018-03-22 | 2019-10-01 | 北京深蓝海生物医药科技有限公司 | 一种盐酸阿托莫西汀的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018895A (en) | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
| US4194009A (en) * | 1974-01-10 | 1980-03-18 | Eli Lilly And Company | Aryloxyphenylpropylamines for obtaining a psychotropic effect |
| JPS5283811A (en) * | 1976-01-01 | 1977-07-13 | Lilly Co Eli | Aryloxy phenyl propylamines and their salts |
| GB1596033A (en) * | 1978-04-25 | 1981-08-19 | Boots Co Ltd | (-)-(2-methoxyphenyl) ethylamine |
| JPS5536403A (en) * | 1978-07-28 | 1980-03-14 | Nippon Iyakuhin Kogyo Kk | Preparation of 1-benzazonine derivative |
| IT1113029B (it) * | 1979-03-01 | 1986-01-20 | Simes | Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro |
-
1981
- 1981-11-12 NZ NZ198953A patent/NZ198953A/en unknown
- 1981-11-12 AU AU77427/81A patent/AU540707B2/en not_active Ceased
- 1981-11-12 RO RO105785A patent/RO83309B/ro unknown
- 1981-11-12 FI FI813589A patent/FI77018C/fi not_active IP Right Cessation
- 1981-11-12 CA CA000389954A patent/CA1181430A/en not_active Expired
- 1981-11-12 GR GR66518A patent/GR75395B/el unknown
- 1981-11-12 PT PT73982A patent/PT73982B/pt not_active IP Right Cessation
- 1981-11-12 ZA ZA817863A patent/ZA817863B/xx unknown
- 1981-11-12 PL PL23378681A patent/PL233786A1/xx unknown
- 1981-11-13 CY CY135081A patent/CY1350A/xx unknown
- 1981-11-13 SU SU813355735A patent/SU1068034A3/ru active
- 1981-11-13 AT AT81305387T patent/ATE6422T1/de not_active IP Right Cessation
- 1981-11-13 DD DD81234837A patent/DD201139A5/de not_active IP Right Cessation
- 1981-11-13 IE IE2661/81A patent/IE52170B1/en not_active IP Right Cessation
- 1981-11-13 DE DE8181305387T patent/DE3162445D1/de not_active Expired
- 1981-11-13 CS CS818359A patent/CS227019B2/cs unknown
- 1981-11-13 JP JP56182953A patent/JPS57114555A/ja active Granted
- 1981-11-13 DK DK502781A patent/DK161887C/da active
- 1981-11-13 HU HU813411A patent/HU185475B/hu not_active IP Right Cessation
- 1981-11-13 PH PH26491A patent/PH17424A/en unknown
- 1981-11-13 EP EP81305387A patent/EP0052492B1/en not_active Expired
- 1981-11-13 ES ES507142A patent/ES8206440A1/es not_active Expired
- 1981-11-13 GB GB8134282A patent/GB2087883A/en active Pending
- 1981-11-14 KR KR1019810004404A patent/KR830007508A/ko not_active Ceased
- 1981-11-14 EG EG662/81A patent/EG15458A/xx active
- 1981-11-15 IL IL64288A patent/IL64288A/xx not_active IP Right Cessation
-
1987
- 1987-02-19 HK HK160/87A patent/HK16087A/en not_active IP Right Cessation
- 1987-12-30 MY MY709/87A patent/MY8700709A/xx unknown
-
1990
- 1990-06-05 JP JP2147166A patent/JPH037250A/ja active Granted
- 1990-06-05 JP JP2147167A patent/JPH037251A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH046699B2 (OSRAM) | ||
| ES2261234T5 (es) | Metabolitos de bupropion y metodos de sintesis y uso. | |
| JPS62230722A (ja) | 肥満および／または関連状態の治療剤 | |
| JP6078059B2 (ja) | 置換シンナムアミド誘導体、その製造方法及び使用 | |
| US20160355457A1 (en) | Solid Forms Comprising(-)-O-Desmethylvenlafaxine And Uses Thereof | |
| RU2057120C1 (ru) | N-алкил-3-фенил-3-(2-замещенный фенокси)пропиламин или его фармацевтически приемлемая кислотно-аддитивная соль, способ его получения, фармацевтическая композиция, обладающая ингибирующей поглощение норминефрина активностью | |
| US20050256206A1 (en) | Enantiomers of O-desmethyl venlafaxine | |
| US20180071230A1 (en) | Formulations, salts and polymorphs of transnorsertraline and uses thereof | |
| US3991207A (en) | Combination therapy for Parkinson's disease | |
| EP0168013B1 (en) | Fluoroallylamine derivatives | |
| US7393977B2 (en) | Dicarboxylic acid salt of sibutramine | |
| US7429679B2 (en) | Sulphonic acid salt of sibutramine | |
| US6552087B1 (en) | Therapeutic agent comprising (+)-sibutramine | |
| JP2004523567A (ja) | テルビナフィンのリンゴ酸付加塩 | |
| US6703406B2 (en) | 2,6-disubstituted piperidines as modulators of nicotinic acetylcholine receptor mediated neurotransmitter release, uptake and storage | |
| US20080200556A1 (en) | Amine Compounds And Inhibiting Neurotrasmitter Reuptake | |
| JPH07252143A (ja) | 認知増強を誘導するベンラファキシン含有医薬組成物 | |
| CA1245673A (en) | Medicine and its preparation | |
| TW202535353A (zh) | 一種ｇｌｐ－１ｒ激動劑醫藥組成物及其應用 | |
| JPS6230168B2 (OSRAM) | ||
| BE878563A (fr) | Nouvelles alpha-alkyl-o-oxybenzylamines, leur preparation et leur application comme medicaments |